GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relief Therapeutics Holding SA (OTCPK:RLFTF) » Definitions » Cyclically Adjusted PB Ratio

RLFTF (Relief Therapeutics Holding) Cyclically Adjusted PB Ratio : 0.49 (As of Dec. 15, 2024)


View and export this data going back to 1990. Start your Free Trial

What is Relief Therapeutics Holding Cyclically Adjusted PB Ratio?

As of today (2024-12-15), Relief Therapeutics Holding's current share price is $4.29. Relief Therapeutics Holding's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 was $8.73. Relief Therapeutics Holding's Cyclically Adjusted PB Ratio for today is 0.49.

The historical rank and industry rank for Relief Therapeutics Holding's Cyclically Adjusted PB Ratio or its related term are showing as below:

RLFTF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.2   Max: 4.3
Current: 0.5

During the past 13 years, Relief Therapeutics Holding's highest Cyclically Adjusted PB Ratio was 4.30. The lowest was 0.01. And the median was 0.20.

RLFTF's Cyclically Adjusted PB Ratio is ranked better than
72% of 600 companies
in the Biotechnology industry
Industry Median: 1.545 vs RLFTF: 0.50

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Relief Therapeutics Holding's adjusted book value per share data of for the fiscal year that ended in Dec23 was $4.816. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $8.73 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Relief Therapeutics Holding Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Relief Therapeutics Holding's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relief Therapeutics Holding Cyclically Adjusted PB Ratio Chart

Relief Therapeutics Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 5.50 1.74 1.28 0.25

Relief Therapeutics Holding Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.28 - 0.25 -

Competitive Comparison of Relief Therapeutics Holding's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Relief Therapeutics Holding's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Relief Therapeutics Holding's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Relief Therapeutics Holding's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Relief Therapeutics Holding's Cyclically Adjusted PB Ratio falls into.



Relief Therapeutics Holding Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Relief Therapeutics Holding's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=4.29/8.73
=0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Relief Therapeutics Holding's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Relief Therapeutics Holding's adjusted Book Value per Share data for the fiscal year that ended in Dec23 was:

Adj_Book=Book Value per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=4.816/106.4612*106.4612
=4.816

Current CPI (Dec23) = 106.4612.

Relief Therapeutics Holding Annual Data

Book Value per Share CPI Adj_Book
201412 16.515 100.704 17.459
201512 -0.033 99.386 -0.035
201612 4.482 99.380 4.801
201712 4.230 100.213 4.494
201812 4.109 100.906 4.335
201912 2.753 101.063 2.900
202012 9.297 100.241 9.874
202112 19.166 101.776 20.048
202212 14.173 104.666 14.416
202312 4.816 106.461 4.816

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Relief Therapeutics Holding  (OTCPK:RLFTF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Relief Therapeutics Holding Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Relief Therapeutics Holding's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Relief Therapeutics Holding Business Description

Traded in Other Exchanges
Address
Avenue de Secheron 15, Geneva, CHE, 1202
Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Its pipeline includes various drug candidates in their different stages of development such as RLF-TD011, and RLF-100, among others. It also has commercial legacy products like Cambia, Setofilm, Voltadol, and Voltfast among others. Geographically the company generates a majority of its revenue from Europe (excluding Switzerland) and the rest from North America, Switzerland, and the rest of the world.